Robotic Joint Replacement Surgeries: How Health Insurance Can Partner In Expanding Access To Advanced Orthopaedic Care For Indian Patients
Dr Jayant Arora shares how health insurance can partner in expanding access to advanced Orthopaedic Care for Indian patients.
Robotic-assisted joint replacement is currently the most advanced and accurate form of surgery available. It enhances surgical precision, ensures better implant alignment, minimizes tissue damage, and allows for faster patient recovery. These clinical benefits are translating into measurable improvements in patient outcomes and satisfaction.
Yet, despite its many advantages, access to robotic-assisted joint replacement is still evolving, particularly when it comes to insurance coverage. While conventional joint replacement procedures are widely supported by most health insurance plans, coverage for robotic-assisted variants is still gaining traction. As the healthcare ecosystem adapts to newer technologies, there is an opportunity for insurers and providers to work together to bridge this gap, ensuring that patients who could benefit from these advanced, minimally invasive procedures are able to access them more easily.
India is witnessing a sharp uptick in the adoption of robotic surgery, with nearly 12,000 robotic- assisted procedures performed in 2022. While this marks encouraging progress, it still represents only a small fraction of the potential demand. By comparison, the United States conducted approximately 876,000 robotic surgeries in 2020 3 and has over 5,500 surgical robots installed for a population of around 330 million 4 . Given India's population of over 1.4 billion and the growing burden of joint-related conditions, the need for wider deployment of robotic technology is clear. There is a significant opportunity and an urgent imperative to scale infrastructure, surgeon training, and insurance coverage to meet this rising demand and ensure equitable access to advanced care.
For patients, the advantages of robotic-assisted joint replacement surgeries are compelling and directly impact their journey to recovery and improved quality of life:
- Less tissue damage: reduced post-operative pain and a more comfortable recovery experience for the patient.
- Increased implant placement accuracy, reducing complications: Precision in implant placement minimizes the risk of complications, potentially preventing the need for revision surgeries and ensuring a longer-lasting solution for the patient.
- Improved mobility and quality of life in the immediate post-operative phase: Patients often experience quicker restoration of movement and a faster return to daily activities
-Shorter hospital stays and quicker recovery: less time away from home and work, reducing the financial and emotional burden on patients and their families.
These benefits are raising patient and healthcare provider awareness and demand, particularly for older people and those with conditions like arthritis. The deployment of robotic technology is expanding beyond renowned private hospitals to community health centres and smaller communities as its cost becomes more affordable, democratizing access to advanced medical care.
The Insurance Regulatory and Development Authority of India (IRDAI) has acknowledged robotic-assisted surgeries under its 'Modern Treatment Techniques' category, a positive step toward broader integration. However, some variability in coverage still exists, with certain policies including sublimits or caps that may unintentionally limit patient access to these advanced procedures. As awareness and clinical evidence continue to grow, there is an opportunity for insurers to revisit these norms in partnership with healthcare providers to better align coverage with evolving standards of care.
By fostering dialogue and collaboration between insurers, regulators, and medical professionals, there is a shared opportunity to re-evaluate coverage policies in light of evolving clinical evidence and patient needs. Expanding coverage for robotic-assisted procedures is not just about technological advancement - it's about enabling more patients to benefit from faster recovery, fewer complications, and improved quality of life.
Together, we can ensure that no patient is left behind due to coverage limitations. By aligning on the shared goal of improved outcomes, we can unlock the full potential of robotic-assisted joint replacement and contribute to a healthier, more resilient India.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
5 homemade drinks that may help manage blood sugar naturally
Not everything that helps your health has to come from a pill bottle. Sometimes, the things we drink at home every day can quietly support the body in powerful ways. If you're someone looking to manage blood sugar levels through natural habits, certain traditional drinks might offer subtle but helpful benefits. These drinks aren't magic fixes, and they aren't meant to replace medicine, but they may give your body a small nudge in the right direction. Here are five simple drinks that many people turn to, passed down through families, whispered between friends, and backed by old wisdom with a touch of modern insight. Fenugreek seed water Soaking fenugreek seeds overnight in water and drinking the strained liquid in the morning is a practice many people swear by. The idea is that fenugreek helps slow sugar absorption and might improve the way your body uses insulin. How to prepare it: Soak about a teaspoon of fenugreek seeds in a glass of water overnight. Drink the water on an empty stomach when you wake up. You don't need to chew the seeds the water itself holds the benefits. Warm cinnamon water Cinnamon is more than just a sweet spice. It has been used traditionally to support digestion, and some believe it may help in keeping sugar levels steady. It's thought to gently help the body respond to insulin more effectively, especially when used regularly in small amounts. How to prepare it: Add half a teaspoon of cinnamon powder (or a small stick) to a cup of boiling water. Let it simmer for a few minutes. Sip it once cooled slightly, either in the morning or after a meal. Bitter gourd juice Not everyone loves the sharp taste of bitter gourd, but its bitter quality is what gives it potential value. It contains natural compounds that act somewhat like insulin, helping cells absorb glucose better. It's a traditional go-to in many Indian households for blood sugar support. How to prepare it: Wash and peel one medium karela. Remove the seeds and blend the rest with a little water. Strain it. Add lemon juice or cucumber to soften the flavor, and drink a small glass before breakfast. Start with once or twice a week. Indian gooseberry water Indian gooseberry, is packed with vitamin C and has been a staple in Ayurvedic remedies. Some believe it helps support pancreatic function and slows down sugar spikes after meals. It's also refreshing and good for your skin and digestion. How to prepare it: Grate or crush fresh amla, or use a tablespoon of unsweetened amla juice. Mix with a glass of water, and drink in the morning or midday. A pinch of black salt can make it tastier. Aloe vera and Tulsi drink Aloe vera is usually linked to skincare, but when taken internally in small amounts, it may help soothe the gut and support better sugar metabolism. Tulsi (holy basil) adds its own benefits, from stress relief to helping balance blood glucose. How to prepare it: Scoop out one tablespoon of aloe vera gel (from the fresh leaf, not the flavored kind). Add 3–4 fresh tulsi leaves. Mix in warm water and let it sit for a few minutes. Drink slowly on an empty stomach. These drinks are simple. No fancy ingredients, no fuss. They're quiet little helpers, not cures, not miracles, but part of a more mindful approach to your health. Before adding anything regularly to your routine, especially if you're on medication or have a condition like diabetes, it's always wise to speak with a doctor or nutritionist. Sometimes, healing begins not in big changes, but in small, steady sips. This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. The drinks and ingredients mentioned are based on traditional practices and emerging insights but are not intended to treat, cure, or prevent any disease. Individuals, especially those with diabetes or on medication, should consult a qualified healthcare provider before incorporating any new remedies into their routine. Always follow your doctor's guidance when managing blood sugar or other health conditions.
Time of India
3 hours ago
- Time of India
Covid vaccine & Karnataka's recent cardiac deaths not linked, finds Jayadeva Institute report
Bengaluru: A state govt-backed study into the alarming rise in sudden cardiovascular events (including heart attacks and cardiac deaths) among youngsters has concluded that Covid-19 vaccination isn't linked to the fatalities. The study categorically states: "There is no single cause behind the observed rise in sudden cardiac deaths; it appears to be a multi-factorial issue with behaviour, genetic and environmental risks." Commissioned by the Siddaramaiah govt and readied by Jayadeva Institute of Cardiovascular Sciences and Research director Dr KS Ravindranath, the sudy follows growing public concern over anecdotal reports of heart attacks and sudden deaths, especially among individuals under 45 years of age, in the state in the post-pandemic era. This multi-disciplinary effort — led by cardiologists, public health experts, virologists and epidemiologists — synthesised national and international data, and included a pilot study of 251 patients admitted to Jayadeva hospital with coronary artery disease between April 1 and May 31 this year. The findings were clear: No evidence was found linking Covid-19 vaccination and increased risk of premature cardiovascular disease. On the contrary, Indian and international studies reviewed by the expert panel suggested that Covid vaccines, particularly inactivated and mRNA platforms, are associated with lower odds of sudden cardiac death. The study also emphasised that most vaccine-related cardiac complications reported globally were rare, self-limiting, and significantly less severe than those caused by the actual Covid-19 infection. You Can Also Check: Bengaluru AQI | Weather in Bengaluru | Bank Holidays in Bengaluru | Public Holidays in Bengaluru Out of the 251 patients studied, nearly all (249) had been vaccinated, with 72% having received two doses and 57% having taken Covishield — the most common vaccine administered in the country. Only 19 patients (7.6%) reported a history of Covid infection, which could be an effect of recall bias (when the survey participant's ability to accurately remember past events becomes flawed over time) or a pointer to the high rate of asymptomatic infections in the population. Effect of lifestyle changes A comparison with pre-pandemic data from 2019 showed a modest rise in conventional cardiac risk factors such as diabetes, hypertension and cholesterol disorders, indicating that lifestyle changes during the pandemic period may be driving the increased cardiovascular burden rather than the virus or the vaccine. The data shows while Covid-19 infection can cause inflammation and clotting abnormalities that increase short-term cardiac risk, there's no scientific evidence to support long-term increased risk due to vaccination. It instead attributes the trend to multiple causes, including rising metabolic disorders, sedentary lifestyles, poor diet, and substance abuse among youngsters.
Time of India
5 hours ago
- Time of India
Antibiotic developed in India proves effective against complicated UTI: Top expert
1 2 3 Pune: An indigenously developed antibiotic has emerged as a "blessing" in the treatment of complicated urinary tract infections (UTIs) among Indian patients, said Dr V Balaji, professor of clinical microbiology at Christian Medical College (CMC), Vellore. Dr Balaji, also a key member of the Indian Network for Surveillance of Antimicrobial Resistance (INSAR) Network, was speaking in Pune at the 13th annual international Best of Brussels symposium on intensive care and emergency medicine held on Saturday. More than 700 critical-care specialists are attending the three-day conference, which began on Friday. About the antibiotic — called cefepime-enmetazobactam — Dr Balaji said it has shown to be "highly effective", especially for treating complicated UTIs. Cefepime-enmetazobactam was fully developed in India, right from conception to trial phases. You Can Also Check: Pune AQI | Weather in Pune | Bank Holidays in Pune | Public Holidays in Pune Dr Balaji said: "Till now, no new drug was ever discovered in India, against cancer, hypertension, diabetes or even antibiotics. But for the first time, chemists in Chennai discovered a new antibiotic called cefepime-enmetazobactam. This is a big achievement because usually, when a drug is discovered abroad, it takes 5–6 years to reach India. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo And when it comes to India, it's 3–5 times more expensive." He added that since the drug discovery was in India, it was released here first at one-tenth of the cost. "It's highly effective and affordable, especially for treating complicated UTIs," he said. At the symposium, doctors also discussed irrational use of antibiotics. They said that in addition to misuse of antibiotics, use of unchecked generic medicines that were freely available in the market was triggering AMR in complicated UTIs. Dr Shirish Prayag, organising chairperson of the symposium and a leading intensivist from Pune, said: "Complicated UTIs are the most common bacterial infections in India. According to WHO, bacterial AMR is directly responsible for nearly 12 lakh deaths worldwide and indirectly responsible for 49 lakh deaths. E. coli and Klebsiella pneumoniae are the most common causes of complicated UTIs. Patients with complicated UTIs, if left untreated, may require surgeries, renal replacement, utmost intensive care and even ventilation that prolongs hospitalisation. " Dr Kapil Zirpe, organizing secretary of the symposium, said: "When E. coli and other pathogens become resistant to anti-infectives like carbapenem, it is termed as carbapenem-resistant Enterobacterales (CRE). In India, mortality associated with CRE infections is as high as 20% to 54.3%, thus underscoring need for newer treatment options. Broad-spectrum antibiotics should not be used if a patient's vitals are fine. In such cases, a moderate-spectrum antibiotic is fine." Dr Subhal Dixit, joint organising secretary of the symposium, said antibiotics should be started only after proper collection of culture. "Antibiotics should always be used cautiously, only with a proper prescription and strictly based on a culture sensitivity–guided protocol."
